Successful Treatment of Ocular Chronic Lymphocytic Leukemia with Ibrutinib: Case Report and Review of the Literature
- PMID: 32509518
- PMCID: PMC7265052
- DOI: 10.1016/j.lrr.2020.100200
Successful Treatment of Ocular Chronic Lymphocytic Leukemia with Ibrutinib: Case Report and Review of the Literature
Erratum in
-
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.Leuk Res Rep. 2022 Mar 24;17:100298. doi: 10.1016/j.lrr.2022.100298. eCollection 2022. Leuk Res Rep. 2022. PMID: 35832061 Free PMC article.
Figures
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA. Cancer J Clin. 2019;69(1):7–34. - PubMed
-
- Moazzam AA, Drappatz J, Kim RY, Kesari S. Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review. J Neurooncol. 2012;106(1):185–200. - PubMed
-
- Treppendahl MB, Andersen N, Jurlander J, Geisler C. A case of chronic lymphocytic leukemia with deletion 17p and bilateral retinal leukemic infiltrates. Eur J Haematol. 2009;82(1):79–80. - PubMed
-
- Grommes C, Gavrilovic IT, Kaley TJ. Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL) J Clin Oncol. 2018
Publication types
LinkOut - more resources
Full Text Sources
